Use of p53-Silenced Endothelial Progenitor Cells to Treat Ischemia in Diabetic Peripheral Vascular Disease [Vascular Medicine]

ConclusionsTransient silencing of p53 using adenoviral vector in EPCs may have a therapeutic role in diabetic peripheral vascular disease.

Source: JAHA:Journal of the American Heart Association - April 1, 2017 Category: Cardiology Authors: Kundu, N., Domingues, C. C., Chou, C., Ahmadi, N., Houston, S., Jerry, D. J., Sen, S. Tags: Gene Therapy, Stem Cells, Diabetes, Type 1, Diabetes, Type 2, Peripheral Vascular Disease Original Research Source Type: research